Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
Cancers|December 24, 2021
The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in CholangiocarcinomaThomas Albrecht, Benjamin Goeppert, Fritz Brinkmann, et al.
Infection|May 11, 2019
Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the fieldU Ateba-Ngoa, J R Edoa, B R Adegbite, et al.
ESMO Open|May 9, 2026
Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunitiesF Nichetti, P Hoffmeister, F Korell, et al.
BMC Cancer|October 7, 2021
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinomaMarcell Tóth, Lilija Wehling, Lena Thiess, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patientsB C Köhler, G M Haag, L Le Cornet, et al.
BMJ Open|June 27, 2025
Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trialRosa Klotz, Cosima Engerer, Solveig Tenckhoff, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 21, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinomaKaiyu Xu, Annika Kessler, Federico Nichetti, et al.
Nature|July 1, 2026
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancerNuria Vaquero-Siguero, Nikolaos Georgakopoulos, Maria C Puschhof, et al.
Molecular Oncology|May 27, 2022
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancersMonica Niger, Federico Nichetti, Andrea Casadei-Gardini, et al.
Cell Death & Disease|October 18, 2020
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerAnna-Lena Scherr, Andreas Mock, Georg Gdynia, et al.
Pageof 26